Stocks STG Financial statements
Financial statementsSunlands Technology Group financial statements
Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data Sunlands Technology Group files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 287 | 315 | 338 | 394 | 337 | 304 | 273 | 289 |
| Cost of revenue | 48.1 | 56.9 | 59.4 | 59 | 50.5 | 37.4 | 43.5 | 37.8 |
| Gross profit | 239 | 258 | 278 | 334 | 286 | 267 | 229 | 251 |
| Research and development | 11.1 | 14.6 | 10.2 | 9.62 | 6.21 | 4.75 | 3.43 | 4.23 |
| Selling and marketing | 313 | 257 | 325 | 274 | 164 | 161 | 167 | 163 |
| General and administrative | 64.5 | 52.2 | 42.2 | 32.6 | 26.9 | 20.2 | 18.2 | 20.6 |
| Operating expenses | 389 | 324 | 378 | 317 | 197 | 186 | 188 | 197 |
| Operating income | -150 | -66 | -99.5 | 17.9 | 89.4 | 81 | 40.8 | 53.8 |
| Interest expense | 0.32 | 2.06 | 1.79 | 1.72 | 1.46 | 1.08 | 0.73 | 0.12 |
| Interest income | 3.96 | 2.54 | 2.36 | 4.38 | 5.32 | 3.38 | ||
| Other non-operating income | 4.67 | 3.06 | 31.1 | 6.14 | 3.56 | 4.8 | 3.6 | 4.31 |
| Pre-tax income | -135 | -56.4 | -66.3 | 31 | 94 | 95.2 | 48.9 | 61.4 |
| Income tax | 0 | 0.35 | -0.04 | -3.08 | 1.74 | 3.55 | 0.18 | 8.48 |
| Net income to minority interests | 0.01 | -0.05 | -0.07 | -1.05 | -0.14 | 0 | 0 | 0 |
| Net income | -135 | -56.7 | -66 | 34.4 | 93.4 | 90.3 | 46.9 | 52.3 |
| EBITDA | -146 | -60.7 | -93.3 | 23.9 | 96.2 | 85.3 | 44.9 | 58 |
| EPS, basic | -21.42 | -8.30 | -9.77 | 5.11 | 13.65 | 13.08 | 6.87 | 7.76 |
| EPS, diluted | -21.42 | -8.30 | -9.77 | 5.11 | 13.65 | 13.08 | 6.87 | 7.76 |
| Shares, basic (weighted) | 6.29 | 6.83 | 6.75 | 6.73 | 6.84 | 6.9 | 6.82 | 6.74 |
| Shares, diluted (weighted) | 6.29 | 6.83 | 6.75 | 6.73 | 6.84 | 6.9 | 6.82 | 6.74 |
Balance sheet
| FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 182 | 201 | 117 | 98.3 | 109 | 108 | 69.5 | 82.3 |
| Short-term investments | 150 | 31.3 | 79.4 | 28.9 | 10.2 | 20 | 37.8 | 33.7 |
| Other current assets | 18.2 | 26 | 18 | 27.7 | 14.2 | 15.4 | 13.3 | 11.8 |
| Total current assets | 376 | 294 | 238 | 177 | 141 | 145 | 121 | 131 |
| Property, plant and equipment | 81.4 | 78.4 | 78.3 | 135 | 118 | 111 | 104 | 94.7 |
| Lease right-of-use assets | 86 | 74.9 | 56.9 | 39.8 | 19.1 | 15.1 | 14.2 | |
| Intangible assets | 0.2 | 0.17 | 0.19 | 0.43 | 0.22 | 0.14 | 0.1 | 0.04 |
| Long-term investments | 4.37 | 5.75 | 9.82 | 8.61 | 10.7 | 8.64 | 35.6 | 45.6 |
| Other non-current assets | 60.9 | 64.3 | 68.1 | 6.3 | 5.49 | 4.67 | 3.61 | 2.82 |
| Total assets | 544 | 570 | 500 | 407 | 330 | 298 | 291 | 293 |
| Accrued liabilities | 66.2 | 62.5 | 93.1 | 92 | 63.3 | 57.7 | 55.5 | 52.3 |
| Deferred revenue | 257 | 240 | 224 | 199 | 143 | 78 | 52.3 | 55 |
| Short-term debt | 4.73 | 4.67 | 4.98 | 6.07 | 5.6 | 5.44 | 0.84 | 0 |
| Total current liabilities | 337 | 322 | 337 | 299 | 214 | 142 | 110 | 109 |
| Long-term debt | 32.8 | 27.7 | 24.6 | 28.6 | 20.8 | 14.7 | 4.85 | 0 |
| Lease liabilities | 88.5 | 81.6 | 63.4 | 45.9 | 22.2 | 18.8 | 18.5 | |
| Other non-current liabilities | 1.65 | 1.18 | 1.84 | 0.98 | 0.99 | 1 | 1.06 | |
| Total liabilities | 593 | 676 | 686 | 566 | 385 | 260 | 208 | 158 |
| Total debt | 37.5 | 32.4 | 29.6 | 34.6 | 26.4 | 20.2 | 5.69 | 0 |
| Paid-in capital | 348 | 340 | 363 | 371 | 335 | 325 | 314 | 327 |
| Retained earnings | -414 | -466 | -563 | -542 | -408 | -306 | -252 | -212 |
| Treasury stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other comprehensive income | 17.3 | 20.5 | 14.8 | 13 | 18.5 | 20.2 | 18.7 | 17.4 |
| Shareholders' equity | -49.3 | -106 | -186 | -158 | -54.3 | 39 | 82.4 | 135 |
| Minority interests | 0.02 | -0.03 | -0.1 | -0.77 | -0.78 | -0.21 | -0.2 | -0.21 |
| Total equity | -49.3 | -106 | -186 | -159 | -55.1 | 38.8 | 82.2 | 135 |
| Total liabilities and equity | 544 | 570 | 500 | 407 | 330 | 298 | 291 | 293 |
Cash flow statement
| FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|
| Net income | -135 | -56.8 | -66.1 | 33.3 | 93.2 | 90.3 | 46.9 | 52.3 |
| Depreciation and amortization | 3.75 | 5.35 | 6.17 | 5.95 | 6.77 | 4.32 | 4.04 | 4.12 |
| Stock-based compensation | 0.56 | 0.43 | 4.56 | 0.12 | 1.04 | |||
| Cash from operations | 26.3 | -76.6 | -28.9 | -58.6 | 1.33 | 19.8 | 26.8 | 21 |
| Capital expenditures | -75.3 | -3.56 | -1.91 | -2.15 | -0.47 | -0.81 | -0.04 | -0.03 |
| Purchases of investments | -633 | -303 | -336 | -288 | -180 | -109 | -238 | -213 |
| Sales and maturities of investments | 0.28 | |||||||
| Cash from investing | -173 | 105 | -53.5 | 53.8 | 13.9 | -10.1 | -49.2 | -1.82 |
| Stock issued | 1.46 | |||||||
| Share buybacks | -4.94 | -4.55 | -4.07 | -0.76 | -0.98 | -0.67 | -1.5 | -0.88 |
| Dividends paid | -4.72 | -4.4 | 0 | |||||
| Cash from financing | 231 | -9.21 | -9.05 | -6.11 | -9.85 | -10.5 | -15.4 | -6.82 |
| Net change in cash | 100 | 22 | -98.3 | -13.2 | 11.7 | 1.26 | -35.5 | 9.94 |
| Free cash flow | -49 | -80.2 | -30.8 | -60.7 | 0.86 | 19 | 26.8 | 21 |
| Interest paid | 0.16 | 2.2 | 1.81 | 1.61 | 1.48 | 1.1 | 0.76 | 0.15 |
| Income taxes paid | 0 | 1.97 | 1.58 | 1.22 | 3.38 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 86.9% | Gross profit / revenue. |
| Operating margin | 18.6% | Operating income / revenue. |
| EBITDA margin | 20.1% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 21.3% | Pre-tax income / revenue. |
| Net margin | 18.1% | Net income / revenue. |
| FCF margin | 7.3% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 7.3% | Cash from operations / revenue. |
| Effective tax rate | 13.8% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 48.1% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 17.9% | Net income / average total assets. |
| Return on invested capital (ROIC) | 129.9% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 1.5% | Research and development expense / revenue. |
| Capex / revenue | 0.0% | Capital expenditures / revenue. |
| D&A / revenue | 1.4% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 5.9% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | -5.0% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | -3.1% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 9.5% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | -4.3% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | -2.0% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | 31.9% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | -15.6% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 29.2% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | -15.5% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income growth, 1y | 11.6% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | -17.6% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS growth, 1y | 13.0% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | -17.2% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | -21.6% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 150.9% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | -21.6% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | 190.1% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value growth, 1y | 64.1% | Book value vs the same period a year earlier. Only from a positive base. |
| Total assets growth, 1y | 0.7% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -3.9% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | -10.1% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | -1.3% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -0.5% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | -0.1% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.21x | Current assets / current liabilities. |
| Quick ratio | 1.07x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 1.07x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 0.00x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 0.0% | Total debt / total assets. |
| Liabilities / assets | 53.9% | Total liabilities / total assets. |
| Net debt | -$116.1M | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | -2.00x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Interest coverage | 441x | Operating income / interest expense. |
| Working capital | $22.6M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 0.0% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $135.2M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.99x | Revenue / average total assets. |
| Fixed asset turnover | 2.91x | Revenue / average property, plant and equipment. |
| FCF conversion | 40.1% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 0.1% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $7.76 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | $7.76 | Net income per basic share, as reported (split-adjusted). |
| Revenue per share | $42.88 | Revenue / diluted weighted shares. |
| FCF per share | $3.11 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $3.12 | Cash from operations / diluted weighted shares. |
| Book value per share | $20.07 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $20.07 | Tangible book value / shares outstanding. |
| Cash per share | $17.23 | (Cash + short-term investments) / shares outstanding. |
| Payout ratio | 0.0% | Dividends paid / net income, when net income is positive. |
| Dividends / FCF | 0.0% | Dividends paid / free cash flow, when free cash flow is positive. |
| Buybacks / FCF | 4.2% | Share buybacks / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $39.1M | Share price x shares outstanding. |
| Enterprise value | -$77.0M | Market cap + total debt - cash - short-term investments. |
| P/E | 0.75x | Market cap / net income. Only when net income is positive. |
| P/S | 0.14x | Market cap / revenue. |
| P/B | 0.29x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 0.29x | Market cap / tangible book value, when positive. |
| P/FCF | 1.87x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 1.86x | Market cap / cash from operations, when positive. |
| FCF yield | 53.6% | Free cash flow / market cap. |
| Earnings yield | 133.7% | Net income / market cap (the inverse of P/E). |
| Dividend yield | 0.0% | Dividends paid over the period / market cap. |
| Shareholder yield | 2.3% | (Dividends paid + share buybacks) / market cap. |
What was Sunlands Technology Group's revenue in fiscal 2025?
Sunlands Technology Group reported revenue of $288.8M for fiscal 2025, 5.9% higher than the year before.
Was Sunlands Technology Group profitable in fiscal 2025?
Yes. Net income was $52.3M, a net margin of 18.1%.
How much free cash flow did Sunlands Technology Group generate in fiscal 2025?
Cash from operations of $21.0M minus capital expenditures of $30.0K left free cash flow of $21.0M.